Assertion Not checkable as stated
A hostile shareholder stagnated Metropolis Healthcare for a decade
“We had a hostile shareholder who just would block everything in the company and not allow things to progress. For 10 years, the company stagnated significantly because this individual would not allow things to move.”
Assertion Supported
Ameera Shah took 600 crore rupees in personal debt for Metropolis buyout
“And honestly, this was a very hard decision because it meant me taking something like a 600 crore debt personally at, you know, an age of 35.”
Insight
Ameera Shah: Luck and timing account for most entrepreneurial success, not capability
“Some of it is short capability, but a luck is most of it. And I think again, recognizing that it's not all us. It's so much about being in the right place, the right time, the right people, the team.”
Disclosure
Ameera Shah rejected the Indian promoter-driven 'Lala company' model for Metropolis
“And I was very clear that I had no interest in building this, like in those days, like a Lala company, as most Indian promoters or a lot of Indian promoters did. I wanted to build something that was clean, with good governance with, you know, an institution th…”
Insight
Indian healthcare diagnostics requires dual selling to doctors and patients
“In healthcare, there is no commonality at all. In India, it was always a retail play where you had to go to doctors and individual consumers and go and convince them that you're worth the salt and build a brand. And our business is not about only going to cons…”
Insight
Healthcare diagnostics businesses cannot be built in five years like consumer brands
“Healthcare is a high gestation business. It is not a business that you can actually build, ah, in one year, two years, or even five years, like you can a consumer brand. This is a business which takes years to earn trust. And to gain experience, and every new …”
Assertion Not checkable as stated
Investors asked 25-year-old Ameera Shah if marriage would end her leadership
“When I was even raising my first round of equity this was 2005, 2006, and I remember the bankers and the investors asking me very clearly, you know, you're 2526 years old. You know, you might be getting married. You'll have kids. Will you stop running this bus…”
Disclosure
Ameera Shah kept Metropolis focused strictly on specialized pathology over general healthcare
“People kept coming to us with opportunities, get into radiology, get into primary care, get into pharmacy, get into this, that, et cetera, hospitals. And I was very clear that either we be a specialist at what we do and we look at a larger canvas, or we stay i…”
Assertion Not checkable as stated
Ameera Shah replaced 22 of the top 25 Metropolis executives in 2016
“In 2016, out of my top 25 people, I changed 22.”
Assertion Supported
Metropolis Healthcare strategically cut international revenue from 15% to 7%
“2016 to 19, we, our international business was 15%, which we exited multiple geographies, and we reduced the international business to seven percent.”
Assertion Supported
Metropolis board deadlock involved 36% Shah, 27% PE, and 36% hostile investor
“I had only 36% shareholding. My private equity at the time had about 26, 27%, and the other hostile investor had 36%.”
Insight
Ameera Shah treats investor capital as a liability, not an asset
“When you invest in Metropolis, this is not an asset. It's a liability because I have your money and I fully recognize that I have your money. And I have to return it with returns. So it's a responsibility that is on me and my company to make sure that you as a…”
Insight
Ameera Shah argues founders must manufacture passion for their given opportunities
“I was never passionate about healthcare, I was never passionate about pathology, but I think it's about realizing that once you're given something, given an opportunity, it's time to seize it and become passionate about it, because it's only with passion, whet…”
Assertion Supported
Ameera Shah scaled Metropolis to 120 labs and 2,400 collection centers
“We've gone from having one lab to having today almost a 120 labs and 2400 centers across five countries.”
Opinion
Ameera Shah: Healthcare is rigid and resistant to new ideas versus tech
“In healthcare people value a lot of experience, and therefore tradition, ways of doing things tend to be quite set and the mindset tends to be a little bit rigid, and people are not always very open to new ideas, unlike the tech world, where it's very differen…”
Assertion Supported
Ameera Shah: Metropolis completed 20 to 25 lab acquisitions since 2004
“So we've done almost something between 20 to 25 deals over the last since 2004.”
Assertion Supported
Diagnostics drive 70% of key healthcare and medical treatment decisions
“In diagnostics, 70% of your key decisions in healthcare and treatment are based on the correct diagnosis.”